As the United States heads into the colder weather months, cases of respiratory syncytial virus (RSV) have been ticking up across the country. For the week ending Nov. 25, there were 8,863 positive ...
Credit: Getty Images. RSV primarily affects children and older adults, and can lead to severe illness or death. Respiratory syncytial virus (RSV) affects infants, young children, and older adults, ...
NEW YORK CITY -- In September, an 8-month-old baby came into Dr. Juanita Mora's office in Chicago with an infection the doctor hadn't expected to see for another two months: RSV. Like her peers across ...
Respiratory syncytial virus (RSV) is a common virus that affects the throat, nose, and lungs. Symptoms include a runny nose, congestion, sneezing, wheezing, cough, and fever, and these are often mild ...
Respiratory syncytial virus (RSV) is a major cause of respiratory infections, particularly in infants, children under 5 years, and older adults. Its rapid spread makes RSV a serious public health ...
Eradivir Inc., the leading clinical-stage biotech company developing antibody recruiting small molecules to treat disease, today announced EV148 as its development candidate for the treatment of ...
A universal respiratory syncytial virus (RSV) immunization program using Sanofi’s Beyfortus (nirsevimab) was associated with ...
6.7-Day Improvement in Time to Complete Resolution of All RSV Symptoms for Patients with Chronic Obstructive Pulmonary Disease (COPD), Congestive Heart Failure (CHF), or Age ≥75 Statistically ...
New data reveals that Montana is among the top states in the nation for protecting infants from Respiratory Syncytial Virus ...
New FDA-approved immunizations are crucial for protecting infants from RSV, a leading cause of hospitalization for babies ...
The vaccine became available in 2023 and has quickly gained usage in the Mountain West.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results